<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00176319</url>
  </required_header>
  <id_info>
    <org_study_id>GI 535/1-1</org_study_id>
    <secondary_id>GI 535/1-1</secondary_id>
    <nct_id>NCT00176319</nct_id>
  </id_info>
  <brief_title>Leipzig Exercise Intervention in Chronic Heart Failure and Aging</brief_title>
  <acronym>LEICA</acronym>
  <official_title>Age-related Functional and Molecular Effects of Short-term Aerobic Endurance Training in Patients With Stable Chronic Heart Failure and Age-matched Healthy Controls.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <brief_summary>
    <textblock>
      In both ageing and heart failure progressive exercise intolerance is observed. The Leipzig&#xD;
      Exercise Intervention in Chronic heart failure and Aging (LEICA) study aims to investigate&#xD;
      how aerobic short-term training interventions affect exercise capacity, left ventricular&#xD;
      systolic and diastolic function, biomarkers of heart failure, skeletal muscle metabolism, and&#xD;
      endothelial function in chronis heart failure patients (CHF-patients) and healthy subjects&#xD;
      (HS) in two different age strata: Above 65 years and below 55 years.&#xD;
&#xD;
      Aim of the trial is therefore to compare the effects of aerobic exercise training in young&#xD;
      and old healthy subjects as well as in young and old heart failure patients. To our knowledge&#xD;
      this study is the first to prospectively investigate age differences of training responses in&#xD;
      both CHF patients and age-matched healthy controls.&#xD;
&#xD;
      Because of the extensive clinical and molecular assessment the results of this trial will be&#xD;
      made public in predefined substudies:&#xD;
&#xD;
        -  LEICA-Echo&#xD;
&#xD;
        -  LEICA-Biomarkers&#xD;
&#xD;
        -  LEICA-Endothelium&#xD;
&#xD;
        -  LEICA-Cardiopulmonary Exercise Function&#xD;
&#xD;
        -  LEICA-Muscle&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 60 healthy subjects and 60 heart failure patients (in each group 30 &lt;55 years, 30&#xD;
      &gt;65 years) are prospectively randomized to either 4 weeks of aerobic ergometer training or&#xD;
      control group.&#xD;
&#xD;
      Before and after the intervention period maximal exercise tolerance is determined by&#xD;
      ergospirometry, endothelial function is measured by high-resolution A-mode ultrasound, left&#xD;
      ventricular function by echocardiography including tissue Doppler imaging, and thigh muscle&#xD;
      mass is assessed by CT. Skeletal muscle biopsies are obtained at both time-points and are&#xD;
      analysed for inflammatory cytokines and markers of catabolism/anabolism.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in functional exercise capacity (as measured by cardiopulmonary exercise testing)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Echocardiography: Improvement in left ventricular diastolic function as assessed by tissue Doppler (E/E' ratio)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of heart failure (including NT-proBNP)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activation of the catabolic ubiquitin-proteasome pathway</measure>
  </secondary_outcome>
  <enrollment type="Actual">120</enrollment>
  <condition>Heart Failure</condition>
  <condition>Ageing</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic endurance exercise training (ergometer)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Group 1: Healthy subjects&#xD;
&#xD;
          -  normal left ventricular ejection fraction (EF) &gt;55%&#xD;
&#xD;
          -  normal coronary artery disease (cardiac catheterization)&#xD;
&#xD;
        Group 2: CHF patients&#xD;
&#xD;
          -  reduced left ventricular ejection fraction (EF) &lt;40%&#xD;
&#xD;
          -  stable clinical condition (NYHA II-III)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  COLD&#xD;
&#xD;
          -  cardiac decompensation &lt;3 months&#xD;
&#xD;
          -  ventricular arrhythmias &gt;Lown IVb&#xD;
&#xD;
          -  myocardial infarction &lt; 4 weeks&#xD;
&#xD;
          -  valvular heart disease &gt;II°&#xD;
&#xD;
          -  insulin-dependent diabetes mellitus&#xD;
&#xD;
          -  arterial hypertension&#xD;
&#xD;
          -  orthopedic conditions prohibiting training participation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rainer P Hambrecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leipzig, Heart Center, Dept. of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan Gielen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leipzig - Heart Center, Dept. of Internal Medicine/Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Volker Adams, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Leipzig, Heart Center, Dept. of Internal Medicine/Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universität Leipzig, Herzzentrum, Klinik für Innere Medizin/Kardiologie</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>July 14, 2009</last_update_submitted>
  <last_update_submitted_qc>July 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2009</last_update_posted>
  <keyword>heart failure</keyword>
  <keyword>ageing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

